CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $79,563
- in 6 filings
Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-06 | Kearney Paul Chief Data Officer | Exercise or conversion · Stock Option (right to buy) | −24,050 | 0 | ||
| 2023-03-07 | CRITCHFIELD GREGORY C Chief Executive Officer | Grant or award | +62,200 | 857,145 | ||
| 2023-03-07 | CRITCHFIELD GREGORY C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +98,300 | 98,300 | ||
| 2023-03-06 | Harrison Robert Gardner Chief Information Officer | Grant or award | +28,500 | 28,500 | ||
| 2023-03-06 | Harrison Robert Gardner Chief Information Officer | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2023-03-06 | Jackson Benjamin General Counsel | Grant or award | +24,700 | 32,700 | ||
| 2023-03-06 | Jackson Benjamin General Counsel | Grant or award · Stock Option (right to buy) | +39,100 | 39,100 | ||
| 2023-03-06 | MOYES JAY M Chief Financial Officer | Grant or award | +32,800 | 35,630 | ||
| 2023-03-06 | MOYES JAY M Chief Financial Officer | Grant or award · Stock Option (right to buy) | +51,800 | 51,800 | ||
| 2023-03-06 | Boniface John J. Chief Scientific Officer | Grant or award | +22,100 | 69,454 | ||
| 2023-03-06 | Boniface John J. Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +34,900 | 34,900 | ||
| 2023-03-06 | Kearney Paul Chief Data Officer | Grant or award | +16,000 | 16,000 | ||
| 2023-03-06 | Kearney Paul Chief Data Officer | Grant or award · Stock Option (right to buy) | +25,300 | 25,300 | ||
| 2023-03-06 | Altomare Nadia Chief Commercial Officer | Grant or award | +18,300 | 18,300 | ||
| 2023-03-06 | Altomare Nadia Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +28,900 | 28,900 | ||
| 2023-03-06 | Foley Michael R Chief Medical Officer | Grant or award | +27,000 | 27,000 | ||
| 2023-03-06 | Foley Michael R Chief Medical Officer | Grant or award · Stock Option (right to buy) | +42,700 | 42,700 | ||
| 2022-09-08 | Boniface John J. Chief Scientific Officer | Exercise or conversion | +844 | $0.73 | $616 | 47,354 |
| 2022-09-08 | Boniface John J. Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −844 | 0 | ||
| 2022-07-27 | Boniface John J. Chief Scientific Officer | Exercise or conversion | +1,000 | $0.73 | $730 | 47,510 |
Page 17 of 23 · 457 trades